SGLT2i vs bolus insulin as add-on to stable basal insulin treatment in type 2 diabetes and risk of cardiovascular disease and mortality: a nationwide observational studyShow others and affiliations
2018 (English)In: Diabetologia, ISSN 0012-186X, E-ISSN 1432-0428, Vol. 61, p. S58-S59Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
Springer, 2018. Vol. 61, p. S58-S59
National Category
Endocrinology and Diabetes
Identifiers
URN: urn:nbn:se:uu:diva-367125ISI: 000443556001113OAI: oai:DiVA.org:uu-367125DiVA, id: diva2:1267139
Conference
54th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), OCT 01-05, 2018, Berlin, GERMANY
Funder
AstraZeneca2018-11-302018-11-302018-11-30Bibliographically approved